Back to Search
RISHI BHARGAVA, MD
MD
Emergency Medicine Physician
NPI: 1407811623IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
A82900(CA)
Education
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Class of 2001
Research & Publications (20)
Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers.
PMID 19294003·Int J Clin Exp Pathol·2009
8-other
Non-invasive detection of superimposed latent fingerprints and inter-ridge trace evidence by infrared spectroscopic imaging.
PMID 19415243·Anal Bioanal Chem·2009
8-other
CK5 is more sensitive than CK5/6 in identifying the "basal-like" phenotype of breast carcinoma.
PMID 18854264·Am J Clin Pathol·2008
8-other
Procedural pain management patterns in academic pediatric emergency departments.
PMID 17363765·Acad Emerg Med·2007
8-other
Use of immunohistochemistry in diagnosis of breast epithelial lesions.
PMID 17471116·Adv Anat Pathol·2007
6-review
Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity.
PMID 17145637·Am J Clin Pathol·2007
4-observational
Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa.
PMID 16532444·Cancer·2006
4-observational
Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: does it measure up to fluorescence in situ hybridization?
PMID 15842048·Am J Clin Pathol·2005
8-other
EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations.
PMID 15920544·Mod Pathol·2005
4-observational
Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH): an alternative and practical method.
PMID 15905689·Diagn Mol Pathol·2005
4-observational
HER-2/neu and topoisomerase IIa gene amplification and protein expression in invasive breast carcinomas: chromogenic in situ hybridization and immunohistochemical analyses.
PMID 15899781·Am J Clin Pathol·2005
8-other
Autosomal dominant inheritance of spondyloenchondrodysplasia.
PMID 15887273·Am J Med Genet A·2005
5-case
Distinction of endometrial stromal sarcomas from 'hemangiopericytomatous' tumors using a panel of immunohistochemical stains.
PMID 15309019·Mod Pathol·2005
4-observational
Gram-Schmidt orthogonalization for rapid reconstructions of Fourier transform infrared spectroscopic imaging data.
PMID 15324507·Appl Spectrosc·2004
8-other
Epstein-Barr virus positive large B-cell lymphoma arising in a patient previously treated with Cladribine for hairy cell leukemia.
PMID 15291365·Leuk Lymphoma·2004
5-case
Prevalence of hepatic steatosis after islet transplantation and its relation to graft function.
PMID 15111501·Diabetes·2004
8-other
Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinoma.
PMID 15538111·Diagn Mol Pathol·2004
4-observational
Time-resolved Fourier transform infrared spectroscopic imaging.
PMID 14658631·Appl Spectrosc·2003
8-other
Colour duplex Doppler ultrasonography evaluation of non-vasculogenic male erectile dysfunction: An Indian perspective.
PMID 12060156·Australas Radiol·2002
8-other
Effective time averaging of multiplexed measurements: a critical analysis.
PMID 11922314·Anal Chem·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1100 WEST STEWART DRIVE
ORANGE, CA 92868 - Phone
- (714) 633-9111
Quick Facts
- NPI
- 1407811623
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 25
- Publications
- 20
Are you this provider?
Claim Your Profile